Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis

Figure 1 Plasma osteopontin in patients with cirrhosis and controls (A) and in patients with cirrhosis in Child-Pugh A, B, and C classes (B). Box-plot graphs, boxes correspond to the median value and interquartile range.

Figure 2 Relationship between hepatic venous pressure gradient and plasma osteopontin concentrations in patients with cirrhosis. HVPG: Hepatic venous pressure gradient.

Figure 3 Cumulative proportion of surviving patients with hepatic venous pressure gradient values below and above 10 mmHg (A) and plasma osteopontin levels below and above 80 ng/mL (B) in the whole group of patients using the Kaplan-Meier method. HVPG: Hepatic venous pressure gradient; OPN: Osteopontin.

Figure 4 Cumulative proportion of surviving patients with hepatic venous pressure gradient values below and above 10 mmHg (A) and plasma osteopontin levels below and above 80 ng/mL (B) in compensated patients without ascites using the Kaplan-Meier method. HVPG: Hepatic venous pressure gradient; OPN: Osteopontin.